MELABLOCK: A Clinical Trial on the Efficacy and Safety of Propranolol 80 mg in Melanoma Patients

NCT02962947 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

546

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: Propranolol
DRUG: Placebo

Sponsor

Azienda Sanitaria di Firenze